Abiopharma

🔍 WEAVER JESSE (Executive)

Company: Holley Inc. (HLLY)

Report Date: 2026-03-04

Detailed Transactions and Holdings:

• Sold 10,141 shares of Common Stock at $3.46 per share (Direct)
  Date: 2026-03-04 | Code: F | equity_swap_involved: 0 | shares_owned_after: 649,318.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 32,983 shares of Common Stock at $3.36 per share (Direct)
  Date: 2026-03-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 616,335.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 111,911 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 728,246.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 4,692 shares of Common Stock (Direct)
  Date: 2026-03-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 732,938.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 38,786 shares of Common Stock at $2.72 per share (Direct)
  Date: 2026-03-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 694,152.00 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: This amount represents shares automatically withheld upon the vesting of 25,770 restricted shares of common stock on March 4, 2026, to cover required tax withholding. The fair market value of HLLY common stock used for purposes of calculating the number of shares to be withheld was the closing price of HLLY common stock as reported on March 4, 2026.
• F2: This amount represents shares automatically withheld upon the vesting of 83,815 restricted shares of common stock on March 8, 2026, to cover required tax withholding. The fair market value of HLLY common stock used for purposes of calculating the number of shares to be withheld was the closing price of HLLY common stock as reported on March 6, 2026.
• F3: Represents a grant of restricted stock units pursuant to the Issuer's 2021 Omnibus Incentive Plan. Each restricted stock unit represents the right to receive, upon vesting, one share of Common Stock. These restricted stock units will vest in equal, or nearly equal, installments on March 13 of each of 2027, 2028, and 2029, subject to the reporting person's continuous employment through such date.
• F4: This amount reflects additional shares issued upon the vesting of performance-based restricted stock units. The number of shares delivered was determined based on the Company's achievement of applicable performance metrics for fiscal year 2025, consisting of Revenue and EBITDA goals. The Company achieved a 110% payout for the relevant performance period, representing an additional 10% of shares above the target award.
• F5: This amount represents shares automatically withheld upon the vesting of 98,564 restricted shares of common stock on March 21, 2026, to cover required tax withholding. The fair market value of HLLY common stock used for purposes of calculating the number of shares to be withheld was the closing price of HLLY common stock as reported on March 20, 2026.